NSC130813

Code: SML0922-25MG D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

NSC130813 blocks protein-protein interactions between XPF and ERCC1, two proteins involved in nucleotide excision repair (NER). The compound, NSC13081...


 En savoir plus

Votre prix
$555.98 25MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

NSC130813 blocks protein-protein interactions between XPF and ERCC1, two proteins involved in nucleotide excision repair (NER). The compound, NSC130813, blocks repair of DNA damage induced by platinum-based ctyotoxic drugs and DNA alkylating agents. NSC130813 synergistically potentiates cell death in cancer cell lines treated with cisplatin or mitomycin C.

Other Notes

air sensitive

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
coloryellow to orange
formpowder
Quality Level100
solubilityH2O: 10 mg/mL, clear
storage temp.−20°C
Cas Number1082532-95-3
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.